Podcasts about Digital health

While Elsevier's most recent Clinician of the Future Report shows increasing adoption of artificial intelligence tools among physicians and nurses, and optimism that they will improve quality of care in the future, a majority raised concerns about trust and reliability. To increase the level of trust, 60% said transparent citations of evidence-based and peer-reviewed research will be key. How to provide that transparency is our focus today as Raise the Line host Lindsey Smith welcomes Elsevier colleagues Rhett Alden and Raman Kaur to guide us through the complexities involved, including the concept of traceability and what role it plays in how AI tools such as Elsevier's ClinicalKey AI are built and deployed.  “Traceability changes the confidence that a clinician has in an AI tool so that they aren't trusting the AI, they're trusting the underlying evidence they're consuming from the AI-assisted platform,” says Raman, who brings years of experience as a primary care practitioner to her work.  It's also important, Rhett adds, to provide additional information, pulled from both the clinician's query and the patient's medical record, to inform clinical thinking. “ClinicalKey AI can be more than a response engine by establishing a larger context to provide a more precise answer for that individual patient.” In this thought-provoking discussion, these experts also provide insights on: Mitigating bias in AI results; Using AI responsibly with sustainability in mind; What type of clinician will benefit most from AI Mentioned in this episode: ClinicalKey AI Clinician of the Future Report If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Mark Clermont is the CEO of Cecelia Health, and Wendi Mader is the company's Chief Commercial Officer. Cecelia is a virtual multi-specialty medical practice, licensed in all 50 states, that helps employers, payers, health systems, and life sciences companies manage chronic and cardiometabolic disease and bring down the cost of care. It's not a point solution. It's a medical practice that prescribes and manages medication (including GLP-1s, from prescribing through titration and side-effect management), runs intensive nutrition therapy, and handles behavior and lifestyle care, all through a team of RNs, RDs, certified diabetes educators, and physicians. The model is built to extend primary care, not replace it, and to coordinate across specialists instead of adding one more disconnected program.Mark and Wendi's argument is simple: chronic disease isn't winning because we lack apps or tools. It's winning because care is fragmented and nobody's tying it together. GLP-1s are making that worse before they make it better. They're the first drug class with indications spanning diabetes, obesity, sleep apnea, fatty liver, and soon addiction, which means a single patient can suddenly need four specialists who don't talk to each other. Cecelia's bet is that a multi-specialty practice can be the layer that connects all of it.We get into:Why chronic disease keeps winning even though there are more apps, tools, and wellness programs than ever, and what point solutions got wrongWhat actually happens to a patient with diabetes and high blood pressure inside Cecelia's model versus the system todayWhy GLP-1s are the first drug class to cross medical specialties, and why that's making fragmentation worse right nowThe patient on a high-dose GLP-1 and an SSRI who almost ended up in the ER, and what the direct-to-consumer prescriber missedHow the US can rank dead last among developed nations and still be the system Mark wouldn't trade for anywhere elseWhere the industry is over-indexing on AI in chronic care, and where Wendi thinks tech actually belongsThe specialty shortage, healthcare deserts, and rural-health funding, and how virtual coordinated care reaches patients brick-and-mortar can'tWhat's different for patients five years from now if Cecelia gets this right—Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations. — Where to find Jared: • X: https://x.com/jaredstaylor • LinkedIn: https://www.linkedin.com/in/jaredstaylor/

In 2020, Emily Mendenhall drove from Washington, DC to Okoboji, Iowa, a town of 800 that swells to 200,000 every summer, and walked into a pandemic that looked nothing like the one dominating national headlines. Inside gas stations and bars, masks marked you as an outsider. In one stop, a man told her family they would not be served if they kept theirs on. Her 6 year old daughter cried, confused. Mendenhall, a medical anthropologist at Georgetown University, did what she always does. She started asking questions. Over months, she interviewed neighbors, former classmates, and local officials, including her own brother in law who helped lead the local COVID response. The result became Unmasked, a case study in how community identity, economics, and politics shaped public health decisions in real time. That work led directly into her latest book, Invisible Illness: A History, from Hysteria to Long COVID, where she tracks a much older problem. Patients with chronic illness, especially women, often fail to meet medicine's demand for proof. Without a clear diagnosis, they lose access to care, insurance coverage, and legitimacy. Mendenhall argues that long COVID did not create this failure. It exposed it.This conversation centers on how healthcare systems reward certainty and punish complexity. Long COVID clinics send patients to 17 specialists without resolution. Insurance structures require diagnoses that many conditions cannot provide. Medical training still struggles to integrate trauma, mental health, and chronic disease into a coherent model of care.Mendenhall brings lived experience into the conversation. After COVID, she dealt with months of fatigue and escalating anxiety that altered her baseline health. She does not claim the label of long COVID, but she understands how quickly the system becomes harder to navigate once symptoms stop fitting clean categories. The stakes are not theoretical. In the United States, access to healthcare, disability benefits, and treatment still depends on whether a condition can be measured, coded, and reimbursed. For millions living with invisible illness, the burden of proof becomes the illness itself.RELATED LINKSEmily MendenhallInvisible Illness: A History, from Hysteria to Long COVIDScience PoliticsGeorgetown UniversityFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Digital health funding is heating up—but where are the dollars going? And what does it mean for health systems' digital health strategies? In this live episode, recorded at Advisory Board's Research Summit, host Abby Burns sits down with Megan Zweig, President and CEO of Rock Health Advisory, for an update on what's going on in the world of digital health funding. Together, they unpack what investment activity looks like and explore questions around what constitutes an investable thesis in 2026, how health systems are—or could be—engaging in the startup ecosystem, and what it takes to be a good incubation partner. We're here to help: Episode | 298: Battle of the bots? Separating AI hype from value in revenue cycle Episode | 254: Stop searching for the “perfect” AI product and do this instead Playlist | Radio Advisory Tech and AI playlist Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Research | AI in healthcare: Evaluating promising use cases Rock Health Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience. The role of pharmacists in cardiometabolic care A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Back by popular demand, 3x Heart of Healthcare guest Eric Larsen joins Steve to answer listener questions on healthcare's AI revolution. Drawing on the ideas behind his latest essay, Healthcare's Oppenheimer Moment, Eric argues that healthcare may be approaching a once-in-a-generation inflection point, and discusses what leaders need to understand before it's too late.We cover:Whether foundation models will eventually outperform healthcare-specific AI companiesWhy healthcare remains stuck in AI pilot projects while the technology races aheadThe biggest obstacle to clinical AI adoptionWhy liability may be the most important (and least discussed) issue in healthcare AIEric's controversial take on how AI will reshape the healthcare workforce—Links:Eric's essay is available here —

In this episode of Clinical Conversations, Dr Emma Spencer discusses the importance of digital health literacy - the ability to access, understand and use digital health tools - with Professor Mahmood Adil, RCPE's outgoing Clinical Data & Digital Health Lead. Prof Adil provides insights into the evolution of digital health and clinical informatics over his career and how doctors can enhance their digital health literacy. The introductory resource on clinical data and digital health can be accessed on RCPE's Education Portal: https://learning.rcpe.ac.uk/data-digitalhealth Professor Mahmood Adil was RCPE's Clinical Data & Digital Health Lead. He is a global expert in clinical data, digital health & innovation fields. He has over 25 years of medical, public health, executive management, academic and policy experience and has delivered on key senior positions in the UK, USA & Middle East. Dr Emma Spencer is Co-Vice Chair - Education of RCPE's Trainees and Members' Committee and resident doctor in internal medicine. RCPE would like to thank Professor Adil for his contributions and service as our Clinical Data & Digital Health Lead. Recording date: 17 April 2026 An extended version of this episode will be released on our sister podcast, Career Conversations, later this year: https://podcasts.rcpe.ac.uk/show/career-conversations/ -- Follow us -- https://www.instagram.com/rcpedintrainees -- Upcoming RCPE events -- https://www.rcpe.ac.uk/events -- Become an RCPE Member -- https://www.rcpe.ac.uk/membership/join-college Feedback: cme@rcpe.ac.uk This podcast is from the Trainees & Members' Committee (T&MC) of the Royal College of Physicians of Edinburgh (RCPE).

James from SomX chatted through all the best news from HLTH 2026, with Motic's Harvinder Power.

The Long View: Building a Health Organization Ready for the Next Decade of AI What does it take to build a health organization that will still be running on a strong digital and AI foundation in five years, ten years, or twenty? In this closing conversation, John Henderson, Vice President and Chief Information and Digital Officer at Rady Children's Health, takes the long view. Drawing on his work leading the digital integration of CHOC into Rady Children's Health, launching private generative AI platforms to support clinical and administrative work, and building an AI-ready data infrastructure that reaches beyond the EHR, John shares what it actually takes to align your organization around a multi-year digital vision. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

AI couldn't cure his mother's stage 4 cancer. It caught three near-fatal errors, found a same-day appointment, and helped her leave on her own terms. When Pratik Desai's mother was diagnosed with stage four duodenal adenocarcinoma — a rare cancer with roughly 3,000 US cases a year — she was nearly discharged without an oncology appointment. Over the next 76 days, Desai used AI at her bedside, from 5am to 10pm, to understand each report, prepare for every appointment, and push a stretched health system to move at the pace her diagnosis demanded. This is a frank account of where AI helped, where it didn't, and the line he refuses to cross. This is a 1:1 interview in The Agentic Patient — a Faces of Digital Health series on how patients and caregivers actually use AI: which tools, which prompts, and which guardrails. GUEST Pratik Desai — New Jersey-based AI practitioner; caregiver and builder of a free, local AI tool for patients HOST Tjaša Zajc — Founder & host, Faces of Digital Health / The Agentic Patient WHAT THE CONVERSATION COVERS - Using AI to interpret a biopsy report and push for a same-day "stat" CT scan - Why AI and the doctors agreed on the care — and clashed on the speed - Finding a same-day oncology appointment through an AI-assisted network search - An error-riddled CT report the AI refused to read — and what it did to trust - Running three Claude "personas" as built-in second and third opinions - A local, open-source AI tool that keeps medical data off the cloud - How to prompt as a patient or caregiver: awareness, knowledge, advocacy — not diagnosis - Where AI failed him: prognosis, and the rule he broke under pressure - Defining quality of life when the outcome is already known CHAPTERS 0:00 How patients use AI — and the guardrails 1:20 Day one: a healthy mother, a diagnosis no one would name 3:34 The first prompt, and pushing for a stat CT scan 7:43 Using AI in the open: agreement on care, friction on speed 9:35 The counterfactual: 76 days with AI at the bedside 12:40 Finding a same-day appointment through a network search 13:40 The CT report the AI refused to read 15:50 When trust erodes: good faith, not competence 18:41 Why switching hospitals wasn't an option 21:54 Defining quality of life: her three goals 28:27 Three Claude personas, and a local private tool 35:12 How to prompt: awareness, knowledge, advocacy — not diagnosis 37:54 Where AI fell short, and the closing asks THE AGENTIC PATIENT SERIES New to the series? Start here → [PASTE PREVIOUS AGENTIC PATIENT EPISODE LINK] All episodes → https://www.facesofdigitalhealth.com/agentic-patient-blog MORE FROM FACES OF DIGITAL HEALTH

Send us Fan MailGLP-1 drugs have produced some of the most consistent weight loss results medicine has ever seen. The business of actually getting them to patients is a different story entirely.David E. Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, break down the CVS Caremark formulary reversal on CareTalk, examining what it reveals about the economics of GLP-1 coverage, and why emerging clinical research on cancer, long COVID, and addiction may push these drugs far beyond their original indication.

How do we move from a healthcare system that only reacts to illness, to one that actively empowers patients? In this episode of The Gritty Nurse Podcast, host Amie Archibald-Varley sits down with Mike Serbinis, the visionary CEO and founder of League, a leading digital health platform transforming the consumer healthcare experience. A seasoned tech innovator and entrepreneur, Mike has a storied history of disrupting industries—from working alongside Elon Musk on early jet propulsion designs to co-founding Kobo, which challenged the global e-reading market. Now, he's turning his sights toward fixing our fragmented healthcare system. Amie and Mike dive deep into how cutting-edge technology, personalization, and AI can bridge the massive gaps in current healthcare delivery, alleviate provider burnout, and truly put the power back into the hands of patients and frontline workers. What We Discuss in This Episode: The Journey to Disruption: How Mike transitioned from mainstream tech innovation to tackling the complex world of healthcare. AI & Digital Platforms: The real-world applications of technology in streamlining care, improving patient outcomes, and modernizing the clinical experience. Empowering the Individual: Shifting the paradigm toward proactive, patient-centered care and navigating the barriers to systemic change. The Future of Care: What a fully integrated, tech-enabled healthcare ecosystem actually looks like for patients and providers on the ground. Chapters 00:00 Introduction to Healthcare Transformation 02:25 Personal Journey into Healthcare Innovation 05:28 The Need for a Consumer-Centered Healthcare System 07:56 Aha Moments: Personal Experiences Driving Change 10:38 Shifting Power Dynamics in Healthcare 13:37 Leveraging Technology to Improve Healthcare Access 15:56 Case Study: Hello Pregnancy Initiative 18:53 AI in Healthcare: Balancing Innovation and Care 22:34 Empowering Clinicians Through Technology 27:31 Building Trust in Healthcare Innovation 31:42 The Digital Front Door to Healthcare 35:13 Preventative Care and the Infinite Care Team 39:45 Hope for the Future of Healthcare Connect with Mike & League: LinkedIn: Michael Serbinis Website: League.com X (Twitter): @mserbinis   Listen on Apple Podcasts – : The Gritty Nurse Podcast on Apple Apple Podcasts  https://podcasts.apple.com/ca/podcast/the-gritty-nurse/id1493290782 * Watch on YouTube –  https://www.youtube.com/@thegrittynursepodcast Stay Connected: Website: grittynurse.com Instagram: @grittynursepod TikTok: @thegrittynursepodcast Facebook: https://www.facebook.com/profile.php?id=100064212216482 X (Twitter): @GrittyNurse Collaborations & Inquiries: For sponsorship opportunities or to book Amie for speaking engagements, visit: grittynurse.com/contact Thank you to Hospital News for being a collaborative partner with the Gritty Nurse! www.hospitalnews.com 

It's been one year since the U.S. Centers for Disease Control and Prevention, in an unprecedented move, dismissed all the members of its Advisory Committee on Immunization Practices (ACIP), kicking off what would turn out to be a very concerning and busy year for infectious disease specialists.  We're going to recap this turbulent period – which includes a resurgence of measles, an unusually rough flu season, the emergence of a new COVID strain and outbreaks of hantavirus and Ebola – with Dr. William Schaffner, one of the country's most frequently quoted medical experts on infectious disease, vaccination, and public health. As a member of ACIP for decades, Dr. Schaffner brings unique insight into the dismantling of the committee and the distrust of vaccines that lies at the root of the changes. As he explains to Raise the Line host Lindsey Smith, while many vaccine critics are beyond reach, there are those he describes as vaccine hesitant that may be persuadable if the right approach is taken. “Beyond providing facts, we have to listen to them and respond to their concerns and make them feel comfortable. Information is fundamental, but behavior change only comes with a change in attitude.” Tune in for a wealth of wisdom and context that includes observations on: What's complicating containment of the Ebola outbreak; Challenges in public health communication in the current social media environment; What grade health authorities should get on their response to the hantavirus outbreak. Mentioned in this episode:Vanderbilt University School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This week on Pulse: Hot Topics, Louise and George race through a very AI-heavy fortnight — from antibiotics and the menstrual cycle to whether "medical AI" is even a category worth defending.AI and Science. A Nature feature on AI accelerating antibiotic discovery (millions of molecules screened in silico, though only a tiny fraction can actually be synthesised), paired with a UK Biobank study mapping 198 proteins that fluctuate across the menstrual cycle — reframing it as a whole-body biological rhythm, not just a reproductive one.Do We Even Need Medical AI? A NYU study finds frontier general models outperforming purpose-built clinical tools like OpenEvidence and UpToDate — with an important caveat that no patient outcomes were measured. Paired with Apollo, Harvard's foundation model trained on 25 billion clinical events to forecast individual patient trajectories.What If AI Makes Healthcare More Expensive? David Brailer argues in Health Affairs that AI won't lower US health costs because it amplifies the incentives already baked into the payment system — accelerating both better care and billing extraction.The AI Equity Divide. A WHO-led initiative (GI-AI4H) and its RISE framework tackle the risk that AI widens global health inequities when governance lags behind deployment.Governing AI — Local and Professional. Victoria's Department of Health sets top-down standards for AI across public health services, while the American Medical Association champions "augmented intelligence" with clinicians at the centre — two very different models of governance.Plus: the robots now account for 57% of internet traffic, and a shout-out to Daniel McCabe's impact on Australian digital health.Resources:AI is taking on antibiotic resistance Link Plasma proteomic signature of the menstrual cycle LinkGeneralist vs clinical LLMs (OpenEvidence, UpToDate) — NYU study (Vishwanath, Oermann et al.) Link APOLLO healthcare foundation model LinkWhy AI Will Accelerate Health Care Inflation — David Brailer, Health Affairs LinkGlobal Initiative on AI for Health (GI-AI4H) and the RISE framework — npj Health Systems LinkAI guidance for Victorian Public Health Services — Pulse+IT LinkAugmented Intelligence in Medicine — American Medical Association LinkIda Tin — global challenge on continuous hormone monitoring LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material.  People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn  Louise  |  George  |  Pulse+ITFollow us on BlueSky   Louise  |  George  |  Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Ric Sinclair is the CEO of Cotiviti, an enterprise healthcare software and data company that serves hundreds of health plans — including the top 25 in the country — across payment integrity, interoperability, risk adjustment, value-based care, and member engagement, touching coverage for over 300 million patients and members. Cotiviti pairs algorithms and AI with thousands of clinical nurses, MDs, and content experts in a human-in-the-loop model, working across the full administrative ecosystem that moves between payers, providers, patients, and pharma. Ric's core conviction is that healthcare's central problem isn't a data problem or a technology problem — it's a coordination problem, and what the system has never had is a true infrastructure layer to tie it together. Cotiviti isn't trying to pick a side between payers and providers; the bet is that a neutral party sitting in the middle can drive fair, transparent outcomes and pull down the trillion-plus dollars of administrative waste in U.S. healthcare.We discuss:Why healthcare's core problem isn't a data problem or a technology problem — it's a coordination problem, and what it actually takes to build the first infrastructure layer the system has ever hadThe real difference between owning a decade of data assets (and the Edifecs integration) and becoming the infrastructure the industry runs on — and where Cotiviti is in that build todayHow "human in the loop" works at scale — pairing AI with thousands of nurses, MDs, and content experts so every claim is reviewed fairly and problems get predicted before they happenWhy Ric's answer to AI isn't "cut the 10-person team to 2" — it's "take all 10 and do what 50 could," and what that augment-don't-replace math means for client ROIHow you build trust and accountability into an AI workflow rather than bolting it on — and who's accountable when models start shaping decisions about claims and careHow to sit in the neutral middle between payers and providers who don't trust each other — and what it takes to build something both sides actually believe is fairWhat Ric learned as a working drummer in Nashville before healthcare found him — leading without the spotlight, making others better, and why simplicity is a discipline that transfers straight into businessWhat a truly differentiated healthcare platform looks like five years out — and the test Ric uses for what "winning" means: a family of five at the dinner table who never have to think about the administrative machinery behind their care—Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations. — Where to find Jared: • X: https://x.com/jaredstaylor • LinkedIn: https://www.linkedin.com/in/jaredstaylor/

Send us Fan MailSix million healthcare workers are missing today. By 2030, that number reaches 10 million. No amount of training will ever close that gap.In this clip from our episode “Is AI the New Dr. Google?”, host David E. Williams and Bertalan Mesko, Director of the Medical Futurist Institute, break down why the healthcare worker shortage is a mathematical problem that only advanced technology can solve.

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Healthcare is filled with great ideas, promising technologies, and passionate clinicians, but why do so many innovation efforts fail? In this episode, Dale Ellicott joins Dr. Andrea Austin to explore what it really takes to create sustainable change in healthcare. From his early experiences introducing groundbreaking rehabilitation technologies to his current work at Rely Health, Dale shares lessons about resistance to change, organizational alignment, and the importance of putting patients first. Together, they discuss the realities of value-based care, the challenges clinicians face when navigating fragmented healthcare systems, and the growing role of AI in supporting, not replacing human connection. Dale explains how Rely Health combines agentic AI with human care navigators to help patients schedule appointments, access transportation, connect with primary care, and overcome barriers that often lead to poor outcomes and avoidable readmissions. The conversation offers practical guidance for clinicians, leaders, and innovators who want to move beyond pilot programs and build solutions that truly improve healthcare delivery. They discussed: How a values-based decision shaped Dale's career in healthcare innovation Why healthcare organizations struggle to adopt new technology The dangers of "pilotitis" and failed innovation projects How AI-powered care navigation improves patient follow-up Lessons for clinicians who want to become successful change-makers

Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself. Why healthcare AI fundraising has become a tale of two marketsThe two questions dominating investor meetings in 2026The metrics VCs are looking for todayThe debate over whether investors should abandon traditional ownership targetsWhy high valuations can be both a gift and a trap for founders —Show notes:Submit questions for our Eric Larsen healthcare AI Q&A here Part I: AI ate digital health (and what that means for fundraising)Part II: Convicted or disciplined: How healthcare VCs are split on investing—

Learn more about Fibion Student Lab: https://fibion.com/studentlab For any questions and quote, please contact Dr Miriam Cabrita at miriam.cabrita@fibion.com --- Dr Miriam Cabrita has done her Bachelor and Master degrees at NOVA School of Science and Technology in Portugal, and her PhD in biomedical engineering in University of Twente Then she has worked at Roessingh Research and Development Center in Netherlands for 8 years coordinating and managing EU research projects related to eHealth Teaching also courses on Physical Activity, Digital Health and Virtual Coaching at the University of Twente. She has acted as a Board Member for 5 years in International Society for the Measurement of Physical Behaviour (ISMPB) Currently she is working as a Chief Customer Officer at Fibion Inc. _____________________ This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Learn more about Fibion Sleep and Circadian Rhythm Solutions: https://sleepmeasurements.fibion.com/ --- Collect, store and manage SB and PA data easily and remotely - Discover groundbreaking Fibion SENS: https://sens.fibion.com/ --- SB and PA measurements, analysis, and feedback made easy.  Learn more about Fibion Research : fibion.com/research --- Follow Fibion on Twitter https://twitter.com/fibion Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow the podcast on Twitter https://twitter.com/PA_Researcher  

From Clinic to Consumer On How AI Is Reshaping the Entire Health Experience Host: Megan Antonelli Guest: Kenn Harper, GM, Dragon and DAX Copilot, Microsoft Join host Megan Antonelli who sits down with Kenneth Harper, General Manager for Dragon and DAX Copilot at Microsoft, to explore two major moves reshaping health AI. Dragon Copilot has now scaled to more than 100,000 clinical deployments across nine countries, spanning physician, nursing, and radiology workflows, while the newly launched Copilot Health gives patients a unified view of their health data from wearables, EHRs, and lab results, all between clinical visits. Kenneth unpacks what this dual-track strategy means for health systems, clinical teams, and patients, and what health system leaders need to be thinking about right now. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us Fan MailThe World Health Organization projects a global shortage of 10 million healthcare workers by 2030. No training pipeline can close that gap. The only path forward runs through technology.Dr. Bertalan Meskó, Founder & Director of the Medical Futurist Institute, joins host David E. Williams to discuss why digital health is first and foremost a cultural transformation rather than a technological one, and why the most important thing any health system leader can do right now is learn how to use AI as the connective interface between an increasingly complex ecosystem of tools, patients, and clinical teams.

At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"Do nothing for us without us." According to today's guest Robyn Bussey, that operating principle is the basis for effective community health work. "You don't go into a community and dictate. You go and listen and trust and be a partner," she adds. As you'll learn in this enlightening conversation, Bussey is following that approach in her current work as Just Health Director at the Partnership for Southern Equity, an Atlanta-based nonprofit advancing racial equity and shared prosperity across the South.  On this episode of Raise the Line from Elsevier, Bussey provides illuminating  examples of community-rooted work in South Fulton County and rural Georgia, and explains why community health workers may be the most underutilized asset in addressing health disparities. This wide-ranging interview with host Michael Carrese also explores: Bussey's candid perspective on what happened to the surge of interest in health equity that occurred during COVID; Why life expectancy gains in many Southern states have lagged behind the rest of the country; Her advice to students and early-career clinicians about where they're needed most.   Mentioned in this episode:  Partnership for Southern Equity If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This episode of Quality Matters examines the growing role of digital wellness and chronic condition management programs and the challenge of measuring what truly matters. Host Rachel Harrington is joined by Peter Robertson of the Purchasing Business Group on Health and California Quality Collaborative and Kevin Masci of Omada Health to discuss how digital health solutions can help address rising healthcare costs, workforce shortages and fragmented care experiences. Peter and Kevin explain why meaningful engagement goes far beyond app downloads and login counts. Instead, successful programs focus on sustained participation, patient-centered goal setting, integration with primary care and measurable improvements in health outcomes. The conversation explores how employers, health plans and providers are evaluating digital solutions through clinical outcomes, patient-reported outcomes, utilization measures and value-based contracting arrangements. The guests also discuss one of the most important challenges facing digital health: trust. Privacy, transparency, data security and clear communication about how patient data is collected and used all play critical roles in long-term adoption. The episode concludes with a Patient Voice segment featuring Brandee Hicks, who shares her firsthand experiences using digital health tools, highlighting both the convenience they offer and the ongoing challenges around interoperability, digital literacy and maintaining support after programs end.     Highlights Beyond Logins and Clicks Meaningful engagement isn't about how often patients open an app. It's about helping people achieve their health goals through sustained participation and measurable outcomes. Measuring What Matters Guests discuss the growing use of clinical outcomes, patient-reported outcomes, utilization data and value-based contracting to assess digital health program performance. Trust Is Essential Digital health solutions must address concerns around privacy, transparency, data security and how patient information is stored and shared. The Patient Perspective Brandee Hicks shares how digital tools can improve organization, access and self-management while also revealing gaps in continuity, support and interoperability. Looking Ahead The future of digital health depends on better integration with primary care, more personalized engagement strategies and stronger measurement frameworks that prioritize patient outcomes.     Key Quote: "If we're really serious about improving health outcomes, we have to move beyond measuring clicks and logins. The real question is whether people are achieving meaningful progress toward their health goals—and whether these programs are creating lasting value for patients, providers and purchasers alike." — Kevin Masci     Time Stamps: (02:20) Meet Peter Robertson (03:45) Meet Kevin Masci (05:53) Why Digital Solutions Matter (10:01) Care Coordination, Not Care Fragmentation (11:52) Defining Meaningful Patient Engagement (15:07) Why Consistent Measurement Matters (18:32) Measuring Outcomes in Value-Based Contracts (21:12) Data Stratification, Risk Adjustment and Performance Guarantees (27:22) Privacy, Trust and Transparency in Digital Health (30:44) The Future of Digital Wellness and Chronic Care Management (35:08) Patient Voice: Brandee Hicks (40:25) Patient Challenges, Access and Continuity of Care (45:23) Key Takeaways and Closing Thoughts     Dive Deeper: Connect with Peter Robertson Connect with Kevin Masci Connect with Brandee Hicks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What can the rest of the world learn from one of Europe's most impressive digital health ecosystems? This week on Pulse: Amplify, Louise and George sit down with Inma Rodríguez, Market Intelligence Manager at ACCIÓ (Catalonia Trade & Investment), who led the Digital Health in Catalonia Report 2026 — a rare regional analysis that benchmarks Catalonia against the US, Asia and the rest of Europe.Inma unpacks where Europe really sits in the global market (and whether it's keeping pace or falling behind), why digital health growth is settling into a more mature ~5% a year, and whether Europe's focus on regulation, interoperability and data governance is a brake or a long-term advantage. She explains how Catalonia became the 4th region in the world for foreign health-innovation investment, the role anchor investors like AstraZeneca play, and why 65% of the region's digital health companies are building with AI. The conversation also turns to the honest gap revealed in Catalonia's hospital survey — strong ambition, moderate maturity — and the cultural, budget and patient-habit barriers slowing real-world implementation. Inma closes with the seven trends shaping 2026, why AI, personalised medicine and health data spaces top her list, and the 2030 headline she most wants to see.A data-rich conversation for anyone who wants evidence, not hype, about where digital health is heading.Stryker Vocera's Initial Delays Diagnosis Quiz LinkCheck out the ACCIO Report hereConnect with Inma on LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

How can we use digital technology to address children's physical and mental health needs and shift from reactive to anticipatory, personalised care? This episode is the first of a series on research and child health and discusses the role of technology in transforming child health. Professor Paul Dimitri, Director of Research and Innovation at Sheffield Children's NHS Foundation Trust and paediatric endocrinology consultant talks with Nish Talawila Da Camara, Head of Research and Evidence. Paul outlines how digital tools, data and artificial intelligence can be used to build a more proactive and humane system for addressing children and young people's health. There are many exciting advancements in the world of digital health technology, from new infrastructure like the incoming National Centre for Child Health Technology to advancements like remote monitoring, digital twins and AI. But we now face new challenges: Paul emphasises the need for child-focused digital standards and safeguarding measures. As children and young people's physical and mental needs are rising, 'the real opportunity isn't the technology itself. It's what we choose to do with it.' Read our news page summary and download the transcript from episode 1 - on RCPCH website Discover more of our podcasts - on RCPCH Learning The views, thoughts and opinions expressed in this podcast relates only to the speaker and not necessarily to their employer, organisation, RCPCH or any other group or individual. About Paul Professor Paul Dimitri is a Consultant in Paediatric Endocrinology and the Director of Research and Innovation at Sheffield Children's NHS Foundation Trust. He has been working in the field of Paediatrics since 1998 and Paediatric Endocrinology since 2004.  Paul took office as Vice President for Science and Research at the Royal College of Paediatrics and Child Health in early 2022 and is leading on the development of the National Centre for Child Health Technology, aiming to bring together industry, universities, healthcare professionals, children and young people and their families to develop the most advanced healthcare technologies for children worldwide.

This week on the You Are Dope Podcast, Kennedy shares her deeply personal journey of knowing something wasn't right with her health and the frustration of repeatedly being told that nothing was wrong.What followed was years of unanswered questions, self-doubt, and the challenge of advocating for herself when the people she trusted weren't listening.Joining the conversation is Dr. Brandi Sinkfield, a board-certified anesthesiologist, healthcare leader, and founder of Women's Digital Health. She is passionate about helping patients navigate the healthcare system, advocate for themselves, and improve communication with their medical providers—especially when concerns are dismissed or overlooked. Her work focuses on women's health, patient advocacy, and creating better healthcare experiences for all.  Together, we discuss: trusting yourself when something feels off  advocating for your health  navigating difficult healthcare experiences  the importance of being heard  practical ways to speak up for yourself  lessons for patients, families, and healthcare providers This is a conversation about courage, persistence, and the power of trusting your own voice.Because sometimes advocating for yourself isn't optional—it's necessary.

Dr. Sarah Matt trained as a burn surgeon, working in a field where patients arrive with catastrophic injuries and survival depends on speed, skill, and resources. She left the bedside after confronting a limit that medicine does not like to admit. One physician can only see so many people in a day. The system surrounding those patients decides the rest. She moved into health technology, held leadership roles in startups, and built global infrastructure at Oracle to scale care across populations. Then she watched billions of dollars in digital health and AI initiatives stall out when they hit real clinical environments.This episode follows that pivot from surgeon to strategist and back into direct patient care in rural New York, where she now treats uninsured patients, migrant workers, and communities pushed to the margins. The conversation centers on a persistent failure across healthcare systems. Products get built for regulators, executives, and investors instead of the people who use them. The result shows up in failed adoption, broken workflows, prior authorization delays, and rising physician burnout.The discussion cuts through health policy language and lands on lived consequence. The system rewards speed over usability, scale over trust, and compliance over care. Patients absorb the fallout. Physicians carry the liability. The incentives remain intact.RELATED LINKSDr. Sarah MattThe Borderless Healthcare RevolutionThe Clinical RealistJessica FedererSovatoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI ethicist Jess Morley: these chatbots are giving medical advice — so regulate them as medical devices. Part of The Agentic Patient, a Faces of Digital Health series on how patients actually use AI — which tools, which prompts, which safeguards. In this episode, host Tjaša Zajc sits down with Dr Jess Morley, Associate Research Scientist at the Yale Digital Ethics Center and a former AI subject-matter expert at the UK Department of Health and Social Care, for a clear-eyed account of where health AI is going wrong — and how to use it well anyway. Morley argues we systematically overestimate what these tools can do and underestimate the harm. She makes the case for "skeptical optimism," explains why bioethics principles built for one-to-one care break down against many-to-many AI harms, and reframes ambient scribes as inference engines rather than transcription services — with real consequences for coding, billing and patient records. Then she gets practical: the guardrails, prompts and habits patients (and clinicians) can use today. Guest: Dr Jessica Morley — Associate Research Scientist, Yale Digital Ethics Center; formerly UK Department of Health and Social Care and the Bennett Institute, University of Oxford. What the conversation covers: - Why "skeptically optimistic" is the honest position on health AI - AI adoption as "a hammer looking for nails" — and what needs-led design would look like instead - OpenEvidence, EU rules and the question of regulatory capture - The DeepMind–Royal Free case and why law alone isn't enough - Beneficence, non-maleficence, autonomy, justice — and where they fail for AI - Ambient AI scribes, miscoding, billing inflation and phantom tests - Paid vs free models and the widening access gap - The "ask why" rule and knowing when to walk away from a chatbot - Red-teaming your own assumptions and playing models off each other - Building a personal "harness" with skills so AI works from your history - The last-mile problem and the case for regulating LLMs as medical devices - Whether AI is narrowing how clinicians think Chapters: 02:50 — Intro: The Agentic Patient and the case for skeptical optimism 05:52 — "A hammer looking for nails": adoption pressure without a plan 07:25 — OpenEvidence, EU rules and regulatory capture 09:42 — The DeepMind–Royal Free lesson: why law needs ethics 13:29 — The bioethics principles and what they were built to do 19:40 — Autonomy, consent and the ambient-scribe problem 21:49 — Scribes as inference engines: miscoding, fraud and phantom tests 29:06 — Paid vs free models and the access gap 33:25 — Using AI safely: the "ask why" rule 37:38 — Knowing when to walk away: engagement design and degradation 44:58 — Red-teaming and playing models off each other 49:00 — Harnesses and skills: making the model work for you 51:38 — The last-mile problem and regulating AI as a medical device 58:00 — Does AI narrow the clinician's mind? The Agentic Patient series: https://www.facesofdigitalhealth.com/agentic-patient-blog Website: https://www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com LinkedIn: https://www.linkedin.com/company/faces-of-digital-health

Dr. Ami Bhatt is the Chief Innovation Officer for the American College of Cardiology and Chair of FDA's Digital Health Advisory Committee.We discuss the intersection of medicine and technology, highlighting the impact of digital health on chronic disease management, patient education, and access to care. The conversation delves into telemedicine, remote monitoring, patient empowerment, integrative care, and the future of predictive and preventative healthcare.This episode was sponsored by Ardelyx.

Autonomous vehicles may be the closest real-world example of AI operating in life-and-death situations at scale. Justin Norden believes healthcare has a lot to learn from how that industry approached safety, testing, adoption, and trust. This week, Michael and Halle sit down with the founder and CEO of Qualified Health, fresh off the company's $125 million Series B, to discuss why healthcare organizations need to think differently about deploying AI. Justin shares how his experience at Stanford, Apple, Waymo, and in healthcare investing shaped his view that health systems need AI infrastructure, governance, and workforce buy-in, not just another point solution.We cover:What healthcare can learn from Waymo's approach to safe AI deploymentWhat founders need to understand about building around EpicWhy health systems need to treat AI as a CEO-level priority, not an innovation projectHow Qualified Health is helping systems deploy, monitor, and measure AI workflowsWhy governance, safety, and ROI matter as much as model performanceWhy clinicians are right to be skeptical about AI liabilityAbout our guest:Justin Norden, MD is Co-Founder and CEO of Qualified Health building the trusted platform for health system AI. Additionally, he has been an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research where his research and teaching focused on AI in medicine and digital health where he founded and still teaches courses on digital health and generative AI in medicine. Previously, Dr. Norden was Co-Founder and CEO of Trustworthy AI, a company focused on algorithm safety and trust, which was acquired by Waymo (Google Self-Driving). He was a Partner at GSR Ventures leading investments in healthcare and AI, worked on the healthcare team at Apple, and helped start the Stanford Center for Digital Health. Dr. Justin Norden received an MD and MBA from Stanford University, an MPhil in Computational Biology from the University of Cambridge, and a BA in Computer Science from Carleton College.—

Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company's 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.

1 in 3 Women Unscreened On Closing the Cervical Cancer Gap Despite cervical cancer being nearly 100% preventable through routine screening, almost one in three U.S. women are behind, and the numbers have been moving in the wrong direction for a decade. Kara Egan, CEO and Co-Founder of Teal Health, left a career as a health tech investor to fix one of the most overlooked gaps in women's preventive care. In May 2025, Teal received the only FDA authorization for at-home cervical cancer screening, and just seven months later had scaled to all 50 states. In this conversation, Kara breaks down what it actually takes to redesign a screening process that hasn't meaningfully changed in 80 years, how regulatory alignment and updated clinical guidelines are reshaping the landscape, and what at-home diagnostics signal for the future of preventive care and women's health access broadly. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

How do you introduce AI into one of the world's most regulated industries? Dan Herron, Global VP of Digital Health at RWS, joins the Cultural Intelligence Podcast to discuss how life sciences teams can responsibly apply AI in clinical operations, COAs, and linguistic validation: * Why life sciences is uniquely complex for AI adoption, and why regulation, bias, and documentation matter so much * How AI can support faster workflows in low risk areas (green zones), while a human in the loop remains essential for patient facing and regulated content (red zones) * Why the future of linguistic validation is about responsible modernization, not automation for its own sake A conversation on AI with guardrails, the human in the loop imperative, and why the industry can't afford to wait for someone else to go first.

As concerns escalate about the deadly Ebola virus outbreak in Africa, we bring you the unique insights of Dr. Peter Piot, a renowned microbiologist who co-discovered the virus 50 years ago during the first recorded outbreak of the disease. His on-the-ground account of that crisis was provided to us in April before the current outbreak was declared, but it contains valuable historical perspective and shares lessons learned that he carried forward in his consequential career.  “What I saw from the beginning is the most important thing is to listen to people and that you need to act fast to save lives, before you have the evidence you would like to have.”    He followed his contributions on Ebola by diving into the fight against HIV/AIDS, eventually reshaping global response in leadership roles at the World Health Organization and United Nations. As he shares with host Lindsey Smith, the learnings in that case were more pragmatic than scientific. “We had to redefine HIV/AIDS not as a medical problem but as an economic and security problem in order to get it on the political agenda.”  Tune in for a fascinating episode that takes you from the gritty frontlines of public health crises to the battles for funding and attention in the halls of power as Dr. Piot shares what it actually takes to move the world to respond effectively to health threats. Mentioned in this episode: London School of Hygiene & Tropical Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

98% of patients welcome AI in their care — and still want a human in charge. That tension ran through the OECD and Spanish Ministry of Health conference on scaling AI in health (Madrid, late May 2026), and it frames this episode of Faces of Digital Health. Out of 38 OECD countries, only seven have a formal AI strategy and just over a tenth run workforce upskilling programmes — the ambition is outrunning the institutions meant to govern it. Host Tjaša Zajc brings together voices from across the conference to ask what actually has to change: regulation, trust, who gets a seat at the table, and the parts of the agenda nobody is funding. Featuring: - Eric Sutherland — Senior Economist, OECD - Aferdita Bytyqi — Executive Director & Founding Partner, Digital Transformations for Health Lab (DTH-Lab) - Erza Selmani — Research Fellow, DTH-Lab - Valentina Strammiello — Executive Director, European Patients Forum (EPF) - Dr Ricardo Baptista Leite — CEO, HealthAI (the Global Agency for Responsible AI in Health) - Dr Persephone Doupi — Senior Medical Officer, Finnish Institute for Health and Welfare; President, European Federation for Medical Informatics (EFMI) What the conversation covers: - Why trust — not capability — is the binding constraint on health AI adoption - The OECD readiness gap: AI strategies, HTA frameworks and workforce upskilling - How patients really feel about AI: consent forms, transparency, and keeping clinicians central - Why youth health and wellbeing keep getting left out of AI governance frameworks - Five recommendations to make the EU AI Act work for health and competitiveness - Coordinating the EU AI Act, MDR/IVDR and the European Health Data Space - Health technology assessment and reimbursement as the real barriers to scale - AI literacy and prevention: the most underweighted lever in the room Chapters: 0:10 — Welcome: AI in Health & the 2026 OECD Conference in Madrid 0:25 — Key Stats: Only 7 of 38 OECD Countries Have a Formal AI Strategy 2:10 — Eric Sutherland (OECD): We're Not Using Data as Effectively as We Could 3:11 — Afrodita & Erza (DTH Lab): Youth Health Is Missing from AI Governance Frameworks 5:12 — Valentina Stramello (EPF): 98% of Patients Are Positive About AI, But Trust Requires Transparency 7:14 — Dr. Ricardo Baptista Leite (Health AI): 5 Recommendations to Fix EU AI Policy for Health 10:53 — Persephone Doupi (EFMI): We Must Prioritize AI Literacy and Shift Healthcare Toward Prevention —

Send us Fan MailWhat if the tools patients use between therapy sessions mattered more than the sessions themselves?In this clip from our episode “Fixing the Access Crisis In Mental Health”, host John Driscoll and Mark Frank, Co-Founder and CEO of SonderMind, break down how a fully integrated platform combining 80 digital interventions with an AI coach is producing outcomes up to 275% better than traditional therapy alone.Listen to the full episode here

Send us Fan MailAmerican hospitals now spend nearly $2 on administrative overhead for every dollar that touches direct patient care. Insurers earn billions in float by sitting on claims for weeks, providers borrow money just to stay liquid, and patients open bills for visits they barely remember.Don Peterson, Founder and CEO of PIM Health, joins host David E. Williams to discuss why healthcare's payment system is working exactly as it was designed to work, and how real-time claims adjudication at the point of care could eliminate prior authorization as it currently exists, cut administrative overhead from 12 to 15 percent down to 2 to 3 percent, and return hundreds of billions of dollars in waste back to patients, providers, and plan sponsors.

In the late 1980s, a child exposed to fallout from the Chernobyl disaster lay in a hospital bed while doctors told his family there were no clear answers and no reliable path forward. Decades later, that same child, Yan Leyfman, walks into exam rooms as a hematology oncology fellow, expected to deliver clarity inside a system that still runs on delay, uncertainty, and institutional self preservation.This episode traces the throughline from early life shaped by radiation exposure and hospice level uncertainty to a career inside academic medicine, translational research, and oncology media. Yan built his identity around survival and usefulness, moving from patient to physician while carrying the memory of what it feels like to sit on the other side of the table. He helped launch MedNews Week during the COVID crisis to push back on misinformation and expand access to medical knowledge, stepping into a public role while still in training.The conversation stays grounded in the friction between personal narrative and system reality. Clinical training demands efficiency, hierarchy, and emotional distance. Cancer care demands time, clarity, and human connection. Those forces collide in real patient encounters where prior authorization delays, insurance barriers, and fragmented care pathways shape outcomes as much as any treatment protocol.Yan speaks openly about mentorship, belonging, and the drive to make meaning out of survival. The discussion pushes further into what the healthcare system actually rewards, what it quietly strips away, and how quickly empathy can erode under institutional pressure. The episode also examines the role of medical media, where education, industry influence, and narrative control often blur together.This is a conversation about identity under construction, about what happens when someone who remembers powerlessness steps into a role that carries authority, and about whether that memory can survive long enough to change anything.RELATED LINKSYan Leyfman on LinkedInYan Leyfman on InstagramSurviving ChernobylFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Health Affairs Publishing's Rob Lott speaks to Abe Sutton, Director of the Center for Medicare and Medicaid Innovation, about the ACCESS model and broader efforts to test payment and delivery reforms aimed at improving affordability, expanding digital health, and generating real-world evidence in Medicare. Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.

Healthcare is simultaneously propping up the US economy and facing one of its most uncertain moments in years.This month, Halle and Steve unpack the growing contradictions shaping digital health right now: healthcare jobs are driving nearly half of US job growth while provider bankruptcies surge, AI is flooding into healthcare faster than regulators can keep up, and Washington continues to send mixed signals on the future of healthcare policy and innovation.We cover:Why healthcare jobs are now carrying the US labor market and what Medicaid cuts could mean for the economyThe surprising comeback of wearables and how companies like Whoop, Oura, and Google are building massive subscription businessesCMS's new ACCESS model and the debate over whether AI-driven care can actually lower costs without sacrificing qualityThe lawsuit against Character.AI and what it reveals about the growing demand for AI mental health toolsWhy investors are pouring billions into AI drug discovery despite huge unanswered questions about clinical developmentMarty Makary's resignation from the FDA and what ongoing instability means for biotech, pharma, and healthcare innovation—Show notes:Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. (WSJ)Oura Debuts Ring 5, Ahead of Potential IPO (WWD)Whoop Raises $575 Million at $10.1 Billion Valuation (Whoop)Fitbit Ditches the Screen With Its New $99 Whoop Rival (PC Mag)Why big digital health players are missing from Medicare's chronic care experiment (STAT)Character.AI Lawsuit (PA.gov) Marty Makary out as FDA chief (Axios)—

Matthew Zachary is a brain cancer survivor, healthcare advocate, founder of Stupid Cancer and We the Patients, and host of Out of Patients. In April 2026, he returned to the stage at Merkin Hall near Lincoln Center for his first solo public piano concert in almost 22 years while launching his debut book, We the Patients: Understanding, Navigating, and Surviving America's Healthcare Nightmare.What unfolded became far larger than a concert.Over 2 hours, survivors, clinicians, advocates, nonprofit founders, journalists, pharmaceutical sponsors, and healthcare insiders gathered in one room to reflect on 30 years of survivorship, institutional failure, accidental advocacy, and the emotional afterlife of cancer. The evening moved through original piano performances, live chapter readings, and deeply personal conversations about infertility, disability, financial toxicity, insurance denials, grief, burnout, and what happens when patients spend decades navigating systems designed around transactions instead of continuity.Guests including Wendell Potter, Maimah Karmo, Craig Lustig, Shelly Fuld Nasso, Tamika Felder, and others reflected on how the modern cancer advocacy movement emerged largely because patients built parallel systems where healthcare infrastructure failed to meet human needs. The conversation explored how prior authorization, reimbursement incentives, administrative fragmentation, and institutional distrust continue shaping the patient experience across oncology and survivorship.The performance also marked a deeply personal milestone. After brain cancer compromised his left hand at age 21, Zachary spent 6 months rehabilitating both hands to return to public performance for the first time in over 2 decades. The result became part concert, part civic gathering, and part historical record of a generation of survivors who refused to disappear quietly.RELATED LINKSMZLIVE Official WebsiteMZLIVE YouTube VideoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Brian Hasselfeld, MD, Executive Medical Director, Digital Health and Innovation, Associate Director, Johns Hopkins inHealth, Johns Hopkins Medicine, and Primary Care Physician, Johns Hopkins Community Physicians, shares his unconventional journey from investment banking to medicine and discusses how artificial intelligence and digital health are reshaping care delivery.

Send us Fan MailMore than 160 million Americans live in federally designated mental health provider shortage areas. Even those with insurance often spend months searching for a therapist who takes their plan and has availability.Mark Frank, Co-Founder and CEO of SonderMind, joins host John Driscoll to discuss why fixing the provider infrastructure had to come before solving patient access, and how a fully integrated platform combining measurement-based care with AI-powered tools between sessions is producing outcomes up to 275% better than traditional therapy alone.

In December 1996, a 37 year old pharmaceutical executive sat in a Borders bookstore reading medical textbooks on the floor, trying to understand a disease she had never heard of. Multiple myeloma carried a three year prognosis. Her daughter was 18 months old. Her father had just died of cancer. Within weeks, she pushed her doctors to say the quiet part clearly. This would likely end her life before her child entered kindergarten.Kathy Giusti refused to accept passive survival. She built a plan while the system offered fragments. She interviewed oncologists and fertility specialists at the same time. She pursued IVF to have a second child while preparing for treatment. She stayed employed to keep insurance coverage. Every decision carried financial, medical, and emotional risk.That same urgency exposed a deeper failure. Cancer research moved slowly. Academic centers guarded data. Clinical trials lacked coordination. Patients entered a system that demanded compliance without providing clarity. Giusti responded by building the Multiple Myeloma Research Foundation, not as a support group, but as an operating engine to accelerate drug development, fund research, and force collaboration across institutions.This episode tracks the tension between individual agency and systemic failure. Giusti describes how patients navigate diagnosis, insurance barriers, and fragmented care in real time. She explains how data, genomics, and clinical trials reshape cancer treatment while still leaving patients responsible for decisions they are not trained to make. She addresses disparities in access, the limits of early detection, and the reality that progress in oncology often depends on speed, funding, and alignment of incentives.The conversation moves between lived experience and structural critique. It names the cost of delay, the burden placed on patients to act as their own advocate, and the tradeoffs required to push a system forward that still protects itself first.⸻RELATED LINKSKathy GiustiMultiple Myeloma Research FoundationFatal to FearlessAmerican Society of Hematology⸻FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.